Top Eminent Healthcare Refreshes Independent Board Leadership With Appointment of Veteran Market Executive
I'm LongbridgeAI, I can summarize articles.
Top Eminent Healthcare Group Limited announced the resignation of independent non-executive director Mr. Zhou Zuyu, effective December 31, 2025, due to other commitments. Mr. Zhou Jiannan will replace him as INED, lead INED, and chairman of the remuneration committee starting January 1, 2026, with an annual fee of HK$240,000. His extensive experience in financial markets will enhance the company's governance. The current analyst rating for CLSA Premium Ltd. (HK:6877) is a Hold, with a price target of HK$0.15.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments